Coya Therapeutics, Inc. — Investor Relations & Filings
Coya Therapeutics, Inc. is a clinical-stage biotechnology company that develops proprietary biologics and multi-modality therapies designed to enhance the function of regulatory T cells (Tregs). The company's approach focuses on modulating dysfunctional Tregs to suppress inflammation associated with neurodegenerative, autoimmune, and metabolic diseases. Its lead product candidate, COYA 302, is an investigational biologic combination therapy being evaluated for the treatment of Amyotrophic Lateral Sclerosis (ALS). The pipeline also includes other candidates such as COYA 303, a combination of low-dose Interleukin-2 (IL-2) and a GLP-1 receptor agonist, intended for inflammation-driven diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - Coya Therapeutics, Inc. (0001835022) (Filer) | 2026-04-02 | English | |
| EFFECT - Coya Therapeutics, Inc. (0001835022) (Filer) | 2026-03-23 | English | |
| 8-K Filing | 2026-01-30 | English | |
| SCHEDULE 13G/A Filing | 2026-01-30 | English | |
| SCHEDULE 13G/A Filing | 2026-01-28 | English | |
| 4 | 2026-01-26 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 33157224 | 8-K - Coya Therapeutics, Inc. (0001835022) (Filer) | 2026-04-02 | English | ||
| 33012250 | EFFECT - Coya Therapeutics, Inc. (0001835022) (Filer) | 2026-03-23 | English | ||
| 31987353 | 8-K Filing | 2026-01-30 | English | ||
| 31987344 | SCHEDULE 13G/A Filing | 2026-01-30 | English | ||
| 31987320 | SCHEDULE 13G/A Filing | 2026-01-28 | English | ||
| 13347572 | 4 | 2026-01-26 | English | ||
| 13347573 | 4 | 2026-01-26 | English | ||
| 13347576 | 4 | 2026-01-26 | English | ||
| 13347577 | 4 | 2026-01-26 | English | ||
| 13347581 | 8-K | 2026-01-20 | English | ||
| 13347580 | 8-K | 2026-01-08 | English | ||
| 13347582 | 4 | 2026-01-07 | English | ||
| 13347583 | 4 | 2026-01-07 | English | ||
| 13347584 | 4 | 2026-01-07 | English | ||
| 13347585 | 4 | 2026-01-07 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AbbVie Inc.
A research-based biopharmaceutical company developing and m…
|
ABBV | US | Manufacturing |
|
AbCellera Biologics Inc.
Discovers and develops antibody-based therapeutics using a …
|
ABCL | CA | Manufacturing |
|
AbClon Inc.
Develops antibody-based therapeutics using CAR-T, NEST, and…
|
174900 | KR | Manufacturing |
|
ABEONA THERAPEUTICS INC.
A clinical-stage biopharma developing cell and gene therapi…
|
ABEO | US | Manufacturing |
|
ABINGDON HEALTH PLC
A CDMO specializing in lateral flow assays, offering develo…
|
ABDX | GB | Manufacturing |
|
ABIONYX Pharma
Develops biotherapies and drug delivery vectors using apoli…
|
ABNX | FR | Manufacturing |
|
ABIVAX
Clinical-stage biotech developing therapeutics for chronic …
|
ABVX | FR | Manufacturing |
|
Abivax S.A.
Clinical-stage biotech developing miRNA therapeutics for in…
|
ABVX | US | Manufacturing |
|
ABL Diagnostics
Develops molecular diagnostic solutions for managing infect…
|
ABLD | FR | Manufacturing |
|
Abliva
Biopharmaceutical company developing medicines for primary …
|
ABLI | SE | Manufacturing |
Coya Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34219/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34219 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34219 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34219 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34219}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Coya Therapeutics, Inc. (id: 34219)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.